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Questions under study: To examine the associa-
tion between overweight/obesity and several self-
reported chronic diseases, symptoms and disabil-
ity measures. 
Methods: Data from eleven European countries
participating in the Survey of Health, Ageing and
Retirement in Europe were used. 18584 non-in-
stitutionalised individuals aged 50 years and over
with BMI 018.5 (kg/m2) were included. BMI was
categorized into normal weight (BMI 18.5–24.9),
overweight (BMI 25.0–29.9) and obesity (BMI
030). Dependent variables were 13 diagnosed
chronic conditions, 11 health complaints, subjec-
tive health and physical disability measures. For
both genders, multiple logistic regressions were
performed adjusting for age, socioeconomic sta-
tus and behaviour risks.
Results: The odds ratios for high blood pres-
sure, high cholesterol, diabetes, arthritis, joint
pain and swollen legs were significantly increased
for overweight and obese adults. Compared to
normal-weight individuals, the odds ratio (OR)
for reporting 02 chronic diseases was 2.4 (95% CI
1.9–2.9) for obese men and 2.7 (95% CI 2.2–3.1)
for obese women. Overweight and obese women
were more likely to report health symptoms. Obe-
sity in men (OR 0.5, 95% CI 0.4–0.6), and over-
weight (OR 0.5, 95% CI 0.4–0.6) and obesity (OR
0.4, 95% CI 0.3–0.5) in women, were asso ciated
with poorer subjective health (i.e. a decreased risk
of reporting excellent, very good or good subjective
health). Disability outcomes were those showing
the greatest differences in strength of association
across BMI categories, and between genders. For
example, the OR for any difficulty in walking 100
metres was non-significant at 0.8 for overweight
men, at 1.9 (95% CI 1.3–2.7) for obese men, at 
1.4 (95%CI 1.1–1.8) for overweight women, and at
3.5 (95% CI 2.6–4.7) for obese women.
Conclusions: These results highlight the im-
pact of increased BMI on morbidity and disability.
Healthcare stakeholders of the participating
countries should be aware of the substantial bur-
den that obesity places on the general health and
autonomy of adults aged over 50.
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Summary
In recent decades the prevalence of obesity
(body mass index (BMI) ≥30 kg/m2) has dramati-
cally increased in Western societies. While the
adult prevalence of obesity varied from 13% in
1960–1962 [1] to 32% in 2003–2004 [2] in the
United States (US), figures from European coun-
tries also showed an increase in prevalence during
the eighties and nineties [3]. The Surveillance of
Chronic Disease Risk Factors (SuRF) Report 2
estimates that in Europe in 2010 the highest
prevalence of obesity among adults aged >15
years will be found in Greece for men (30%), and
in Greece and the United Kingdom (26%) for
women. Figures for the US are projected to be
44% for men and 48% for women [4].
In industrialised countries, the continuing rise
over time of life expectancy and the trend in the
prevalence of overweight and obesity [1–2, 5–7]
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are of concern since increased healthcare utilisa-
tion and costs are associated with both, and, more
importantly, because it has been estimated that
the rising obesity prevalence may reduce or even
reverse the decline in disability rates expected
among the elderly [8]. In addition, diseases associ-
ated with obesity [9, 10] usually appear during the
second half of life [11], a period during which the
prevalence of overweight and obesity is at its
greatest [12, 13]. 
Several studies investigating the epidemiol-
ogy of obesity and overweight have used data
from the United States and assessed associations
between body weight and diseases. Field [9] and
Must [14] found that the associations between
BMI and several chronic diseases increased with
the severity of overweight both in men and
women, and Patterson has shown that BMI was
also associated with a broad range of self-reported
health complaints [15]. The use of data from vari-
ous European countries [16] or those also includ-
ing health complaints and physical disabilities is
less frequent [15, 17–19].  
This study expands on prior research by ex-
amining the association between BMI and diag-
nosed chronic conditions, health complaints,
overall subjective health and physical disability
using pooled data from nationally representative
samples of community-dwelling individuals aged
050 years in eleven European countries. Because
the associations between BMI and health out-
comes may differ with gender, analyses will be
performed separately for men and women.
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Methods
Setting and participants
This study employed data from the survey of health,
ageing and retirement in Europe (SHARE) [20]. Between
2004 and 2005, SHARE collected data on non-institu-
tionalised individuals aged 050 years. The eleven participant
countries (Austria, Belgium, Denmark, France, Germany,
Greece, Italy, the Netherlands, Spain, Sweden, Switzer-
land) were responsible for drawing representative sam-
ples from their non-institutionalised population, follow-
ing a complex probabilistic multistage design [21]. An
overall response rate of 61.6% was obtained, varying
across countries from 46.9 to 81.0%, except in Switzer-
land and Belgium where it was as low as 38.8% and
39.2%, respectively (table 1) [21]. Using computer-as-
sisted interviewing methods, trained interviewers col-
lected self-reported information through standardised
face-to-face interviews (entire questionnaires and com-
plete SHARE documentation are available online: http://
www.share-project.org/). For this study we excluded 332
persons whose values for height, weight or BMI were
missing or unlikely, and 242 underweight individuals
(BMI <18.5 kg/m2). The final analytic sample consisted of
18,584 subjects.
Body mass index (BMI)
Height and weight were self-reported. Subjects were
classified as being of normal weight (BMI 18.5–24.9 kg/
m2), overweight (BMI 25.0–29.9 kg/m2) or obese (BMI
030 kg/m2). 
Outcome variables
The main binary (0/1) outcome measures were vari-
ous diagnosed chronic conditions (“Has a doctor ever
told you that you had any of the conditions on this card?”,
followed by any heart disease including myocardial in-
farction and congestive heart failure, high blood pressure,
high cholesterol, stroke or cerebrovascular disease, dia-
betes or high blood sugar, chronic lung disease, asthma,
arthritis, osteoporosis, cancer – excluding minor skin can-
cers, gastrointestinal ulcers, cataract) and health com-
plaints (“For the past six months, have you been bothered
by any of the health conditions on this card?” followed by
heart trouble, angina or chest pain, difficulty breathing,
persistent cough, pain in any joint, swollen legs, sleep
problems, falls, fear of falling down, dizziness or black-
outs, gastric or intestinal problems, incontinence or in-
voluntary loss of urine). Depression was measured using
the EURO-D scale, an instrument validated in Europe
which includes twelve items. The presence of clinically sig-
nificant depressive symptoms is defined by a score >3 [22].
Men Women
Response rate Working sample size Overweight Obese Overweight Obese
Austria 55.6% 1775 52.0% 17.9% 35.7% 19.8%
Belgium 39.2% 848 46.5% 19.6% 33.9% 17.5%
Denmark 63.2% 1525 45.4% 14.4% 32.5% 13.8%
France 81.0% 1595 49.0% 15.2% 30.6% 15.7%
Germany 63.4% 2252 51.2% 17.1% 36.9% 17.5%
Greece 63.1% 1930 54.2% 17.0% 42.1% 22.5%
Italy 54.5% 1928 52.9% 16.2% 37.1% 18.1%
Netherlands 61.6% 2208 48.4% 14.1% 36.5% 16.7%
Spain 53.0% 1627 49.4% 20.2% 41.1% 26.9%
Sweden 46.9% 1992 46.9% 13.4% 36.8% 15.8%
Switzerland 38.8% 904 46.7% 13.1% 30.3% 12.7%
Total 61.6% 18584 50.5% 16.5% 36.2% 18.5%
Table 1 
Overweight (BMI
25.0–29.9 kg/m2) 
and obesity (BMI
030.0 kg/m2) popula-
tions’ estimated
prevalence, by gen-
der and country, in
non-institutionalised
individuals aged 
050 years (weighted
results):
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Overall subjective health and physical disability
measures were also considered. The latter included diffi-
culties in any of the following five activities of daily living
(ADL) [23]: bathing, dressing, eating, walking across a
room and getting in or out of bed, as well as difficulty in
walking 100 metres, difficulty in climbing one flight of
stairs, difficulty in climbing more than one flight of stairs
and activity limited by a health problem. 
All the outcome variables were self-reported and
based on a single question, with the exception of depres-
sion, which was measured by a score dichotomised for
analysis. 
Statistical analysis
Separate multiple logistic regressions were used to
assess the association between BMI and each outcome
variable, using the normal weight category as the refer-
ence. Adjustment was made for age, marital status, years
of education, purchasing power parity-household income
(euros) [21] adjusted for size of household, smoking,
physical activity and country. For subjective health and
disability outcomes we run supplementary logistic re-
gressions adding the following adjustment variables:
heart diseases, chronic lung diseases, stroke, cancer, dia-
betes and arthritis. Analysis took account of the complex
sampling design (data weighted for age, gender, non-re-
sponse and sampling scheme) to make samples represen-
tative of each country’s population. The joint Wald test
was used to evaluate the interaction between BMI and
gender, and all analyses presented were performed sepa-
rately for men and women. None of the variables consid-
ered had missing data 02%.
We used Stata 8.0, and considered P values <0.05 as
significant.
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Results 
The estimated prevalence of excess body
weight and obesity by gender, overall and across
countries, is shown in table 1. According to the
SHARE data, 36.2% and 18.5% respectively of
European women, and 50.5% and 16.7%, respec-
tively, of European men, were overweight or
obese. These data also highlight that Austria,
Greece, and Spain had the highest prevalence of
obesity among both men and women. Character-
istics of the male and female populations are given
in table 2.
Table 3 shows the adjusted odds ratios for
self-reported diseases, health complaints, and sub-
jective health and physical disability measures. In
men and women, overweight and obesity were as-
sociated with significantly increased odds of re-
porting two or more chronic diseases. For over-
weight and obesity, the odds for high blood pres-
sure, high cholesterol, diabetes and arthritis were
significantly and similarly increased for men and
women. In addition, obese men and women were
at elevated risk of any heart diseases and depres-
sion. 
The adjusted odds for presenting two or more
health complaints were augmented for overweight
and obese individuals, irrespective of gender.
Overweight and obese women were more likely to
report symptoms; they were actually at increased
risk of reporting gastrointestinal problems, incon-
tinence, falls, fear of falling down, having joint
pain or swollen legs. The latter two symptoms
were also significantly associated with obesity and
overweight in men. Obese men and women were
also at increased risk of reporting heart trouble or
angina, and sleep problems.
Obese men and women and overweight
women were significantly less likely to report ex-
cellent, very good or good subjective health, and
more likely to report difficulties in all five physical
disability outcomes. However, the associations
Men Women
(n = 8607) (n = 9977)
Age, mean (SD) 64.1 (0.2) 66.2 (0.2)
≥12 years of education, % 49.6 37.5
PPP-household income (Euros)
25th percentile 13064 10674
50th percentile 22750 18924
75th percentile 38674 33411
Married or registered partnership, % 76.7 55.7
Currently smoking, % 24.3 12.8
Neither moderate nor vigorous physical activity, % 9.1 14.7
Number of chronic diseases, %
0–1 60.8 53.4
2 or more 39.1 46.5
Number of health complaints, %
0–1 69.3 52.8
2 or more 30.6 47.2
Excellent / very good / good subjective health, % 67.9 60.6
Difficulties in any of 5 activities of daily living, % 9.0 12.1
Table 2 
Characteristics of the
pooled SHARE study
population, by gen-
der (weighted results,
n = 18 584):
261-266 Pey12067.qxp  18.4.2008  8:40 Uhr  Seite 263
were stronger for women than for men. After ad-
ditional adjustment for chronic diseases, the sig-
nificant odds ratios for disability and subjective
health decreased only slightly (results not shown). 
Overall, overweight had a greater impact on
health outcomes in women than in men. Also, for
most outcomes, particularly those with statisti-
cally significant results for overweight and obe-
sity, a “dose-response” relationship was noted
with  increasing body weight. Cancer, gastroin-
testinal ulcers and persistent cough were not
 associated with body weight. 
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Men Women
Overweight Obesity Overweight Obesity
OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Self-reported diseases1
Diabetes or high blood sugar 1.6* 1.3–2.1 3.1* 2.4–4.3 1.7* 1.3–2.2 3.8* 2.8–5.0
High blood pressure 1.8* 1.6–2.2 2.9* 2.3–3.5 1.7* 1.5–2.0 3.3* 2.8–4.0
High cholesterol 1.5* 1.3–1.8 1.4* 1.1–1.8 1.2* 1.1–1.4 1.4* 1.2–1.7
Arthritis 1.2 1.0–1.5 1.5* 1.2–1.9 1.3* 1.1–1.5 1.7* 1.4–2.1
Any heart disease 1.1 0.9–1.4 1.6* 1.2–2.1 1.1 0.8–1.4 1.7* 1.3–2.2
Cataract 1.2 0.9–1.6 1.7* 1.2–2.5 1.0 0.8–1.3 1.5* 1.1–2.1
Asthma 1.0 0.7–1.5 1.4 0.9–2.3 1.6* 1.2–2.2 1.9* 1.4–2.7
Stroke or cerebral vascular disease 1.2 0.8–1.7 1.3 0.8–2.1 1.6* 1.1–2.4 1.1 0.7–1.8
Chronic lung disease 0.8 0.6–1.0 1.3 0.9–1.9 1.2 0.9–1.7 1.5* 1.1–2.1
Osteoporosis 0.9 0.5–1.3 1.9* 1.0–3.0 1.0 0.8–1.2 0.9 0.7–1.1
Depression 1.1 0.9–1.3 1.3* 1.1–1.8 1.0 0.9–1.2 1.2* 1.0–1.5
Cancer (excluding minor skin cancers) 0.9 0.6–1.2 1.0 0.6–1.6 1.2 0.9–1.7 1. 0.8–1.7
Gastrointestinal ulcers 0.9 0.7–1.1 1.2 0.9–1.7 1.2 0.9–1.6 1.1 0.8–1.6
2 or more chronic diseases 1.4* 1.2–1.6 2.4* 1.9–2.9 1.5* 1.3–1.7 2.7* 2.2–3.1
Health complaints2
Swollen legs 1.8* 1.3–2.5 5.0* 3.5–7.1 1.9* 1.5–2.3 4.4* 3.6–5.4
Pain in any joint 1.2* 1.0–1.3 1.8* 1.5–2.1 1.4* 1.2–1.6 2.1* 1.7–2.5
Difficulty breathing 1.2 0.9–1.6 2.3* 1.7–3.1 1.6* 1.3–1.9 2.5* 2.0–3.1
Dizziness, faints or blackouts 1.1 0.9–1.5 1.6* 1.1–2.2 1.1 0.9–1.4 1.2 0.9–1.5
Heart trouble or angina or chest pain 1.1 0.9–1.4 1.5* 1.1–2.1 1.1 0.8–1.5 1.6* 1.2–2.1
Incontinence or involuntary loss of urine 1.2 0.8–1.6 1.2 0.7–2.0 1.4* 1.0–1.8 2.6* 1.9–3.5
Falls 1.1 0.7–1.8 1.3 0.7–2.3 1.3* 1.0–1.8 1.9* 1.4–2.7
Fear of falling down 1.3 0.9–1.8 1.5 0.0–2.3 1.2 0.9–1.5 2.0* 1.6–2.6
Stomach or intestine problems 0.8* 0.6–0.9 0.9 0.7–1.2 1.2 1.0–1.4 1.2 1.0–1.5
Sleeping problems 1.2 1.0–1.5 1.6* 1.2–2.1 1.1 1.0–1.3 1.3* 1.1–1.5
Persistent cough 0.9 0.7–1.2 0.9 0.6–1.4 1.2 0.9–1.5 1.2 0.8–1.7
2 or more symptoms 1.1* 1.0–1.3 2.0* 1.6–2.5 1.4* 1.2–1.6 2.3* 1.9–2.7
Subjective health
Excellent, very good, good 0.9 0.7–1.0 0.5* 0.4–0.6 0.7* 0.6–0.8 0.4* 0.3–0.5
(versus fair or poor)
Physical disability
Difficulty in climbing >1 flight of stairs 1.3* 1.0–1.6 2.4* 1.9–3.1 1.6* 1.4–1.9 3.4* 2.9–4.1
Difficulty in any of 5 ADL 1.2 1.0–1.6 2.2* 1.6–3.1 1.3* 1.0–1.6 2.4* 1.8–3.1
Difficulty in walking 100 m 0.8 0.6–1.1 1.9* 1.3–2.7 1.4* 1.1–1.8 3.5* 2.6–4.7
Difficulty in climbing 1 flight of stairs 1.0 0.8–1.4 1.6* 1.1–2.2 1.4* 1.1–1.7 2.9* 2.3–3.8
Activity limitations due to health problems 1.0 0.9–1.2 1.7* 1.4–2.0 1.3* 1.1–1.5 2.1* 1.8–2.4
† Adjustment was made for age, years of education, ppp-household income (power parity-household income), marital status, 
smoking status, physical activity and country.
* P <.05
ADL: activity of daily living
1 Physicians’ diagnosed chronic conditions (“Has a doctor ever told you that you had any of the conditions on this card?”): 
high blood pressure or hypertension; high blood cholesterol; stroke or cerebrovascular disease; diabetes or high blood sugar; chronic
lung disease such as bronchitis or emphysema; asthma; arthritis, including osteoarthritis or rheumatism; osteoporosis; cancer or malig-
nant tumour, including leukaemia or lymphoma, but excluding minor skin cancers; stomach or duodenal ulcer, peptic ulcer; cataract.
2 Health complaints (“For the past six months, have you been bothered by any of the health conditions on this card?”): pain in your 
back, knees, hips or any other joint; heart trouble or angina, chest pain during exercise; breathlessness, difficulty breathing; persistent 
cough; swollen legs; sleeping problems; falls; fear of falling down; dizziness, faints or blackouts; stomach or intestine problems; 
including  constipation, air, diarrhoea; incontinence or involuntary loss of urine; other symptom, not yet mentioned.
Table 3
Adjusted odds ratios†
(95% CI) for self-re-
ported diseases,
health complaints,
subjective health and
physical disability,
according to BMI (ref-
erence = normal
weight category):
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In this study we have observed that the odds
ratios for high blood pressure, high cholesterol,
diabetes, arthritis, joint pain and swollen legs
were significantly increased for overweight and
obese adults. While overweight and obese women
were more likely to report several health symp-
toms, obesity in men, and overweight and obesity
in women, were associated with poorer subjective
health. Disability outcomes were those showing
the greatest differences in strength of association
between gender and across BMI categories. Obe-
sity, but not overweight, was consistently signifi-
cantly related to physical disability measures,
 subjective health and most diseases and health
complaints. However, although results suggested
a “dose-response” relationship with increasing
body weight in both genders, it was mainly in
women that overweight was associated with a sig-
nificant risk of reporting all physical disability
measures and almost all health complaints. 
These findings are generally in agreement
with those of other studies, despite different study
designs, samples, settings, ways of evaluating
height and weight, BMI cut-offs and variables
considered for adjustment. Indeed, population-
based cross-sectional studies and prospective
 cohorts pointed to a dose-response relationship
between BMI and health outcomes, with increas-
ing risk of developing numerous conditions in
both genders [9, 14]. In addition, similar trends
towards augmented risk, for men and women,
were found for the vast majority of the 41 self-re-
ported physician-diagnosed conditions and health
complaints considered by Patterson [15].
Results from other population-based studies
have shown significant associations between BMI
and physical disability, with stronger effects for
obese women than for obese men, and often with
an increased risk of disability for overweight in
women only [13, 24–27]. Of these studies, how-
ever, only a few have assessed diseases and/or
health complaints in addition to disability out-
comes [13, 25, 27]. In fact, based on measured
BMI, Lean [25] observed that, compared to nor-
mal weight individuals, obese/overweight women
were significantly more likely to report symptoms
and difficulties in physical functioning than over-
weight/obese men. 
Despite gender discrepancies in the associa-
tion between BMI and disability, and other rea-
sons for analysing men and women separately [17,
25], some authors included only one gender [18,
19] or omitted gender stratification [28–30] and
were thus prevented from identifying the higher
risk of physical disability found for women. This
lesser negative impact of overweight found in
men compared to women deserves comment. It
may be explained by the survivor effect [12] or by
differences in disability-free life expectancy be-
tween genders, with elderly men representing a
healthier group than elderly women. Another ex-
planation may be the greater contribution of
muscle mass to BMI in men [25]. Indeed, individ-
uals with excessive adiposity and low muscle mass
have more difficulty with daily activities than
those with appropriate muscle mass, muscle
strength here being inadequate for body weight.
It may also be that women in general are more
likely to report health problems to their physi-
cians.
A large database combining nationally repre-
sentative samples from eleven European countries,
the use of a standardised questionnaire and the
availability of a data set allowing comprehensive
adjustments were the main strengths of this study.
However, some limitations must be considered.
The first was the fact that height and weight were
self-reported. Because men and women generally
overestimate their height and underestimate their
weight, particularly if they are obese, BMI tends
to be underestimated [31] and associations be-
tween BMI and outcomes may tend to be overes-
timated [32]. The true percentage of overweight
and obesity may therefore be higher than our
 estimates. As the degree of height and weight
 misreporting across countries is unknown, cau-
tion must be exercised in comparing overweight
and obesity prevalence. Secondly, selection bias
cannot be ruled out because the overall response
rate was moderate (62%), in particular due to
poor participation in Switzerland (39%). In spite
of this, the age, gender, subjective health and BMI
characteristics of the Swiss sample were similar to
those of the 2002 Swiss Health Care Survey (un-
published results), and the trends in prevalence of
overweight and obesity of the eleven European
countries considered in this study were close to
those presented in the Surveillance of Risk Factor
report 2 published by the WHO [4]. Finally, due
to the cross-sectional nature of the analysis,
causality cannot be inferred. Whether overweight
and/or obesity appeared before or after the onset
of the health outcomes cannot be determined.
However, longitudinal studies have already shown
that obese individuals were at increased risk of de-
veloping diseases and disability [9, 13].
This study investigated the association be-
tween body weight and health. The results from
the eleven European countries included in SHARE
highlight the burden that increased BMI places on
health complaints and disability, parti cularly for
women. Because of the considerable long term care
costs generated by functional losses, the  impact on
disability, from an economic perspective, may be
higher than the impact of other specific diseases
[33–34]. Healthcare professionals and politicians of
the participant countries should be aware of the
substantial burden that increased body weight
places on the general health of adults aged over 50
years and their healthcare systems.
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This paper uses data from the release 2 of SHARE
2004. The SHARE data collection has been primarily
funded by the European Commission through the 5th
framework programme (project QLK6-CT-2001-00360
in the thematic programme Quality of Life). Additional
funding came from the US National Institute on Aging
(U01 AG09740-13S2, P01 AG005842, P01 AG08291,
P30 AG12815, Y1-AG-4553-01 and OGHA 04-064).
Data collection in Austria (through the Austrian Science
Fund, FWF), Belgium (through the Belgian Science 
Policy Office) and Switzerland (through BBW/OFES/
UFES) was nationally funded. For methodological details
see Börsch-Supan and Jürges (2005).
Correspondence:
Isabelle Peytremann-Bridevaux, MD, MPH,
DSc
Institute of Social and Preventive Medicine
17 Bugnon
CH-1005 Lausanne
Switzerland
E-Mail: Isabelle.Peytremann.Bridevaux@chuv.ch
266Health correlates of overweight and obesity in adults aged 50 years and over
References
1 Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence
and trends in obesity among US adults, 1999–2000. JAMA.
2002;288:1723–7.
2 Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ,
Flegal KM. Prevalence of overweight and obesity in the
United States, 1999–2004. JAMA. 2006;295:1549–55.
3 Seidell JC. Obesity in Europe: scaling an epidemic. Int J Obes.
1995;19:S1–S4.
4 World Health Organization. The SuRF Report 2. Surveillance
of chronic disease Risk Factors: country-level data and compa-
rable estimates. Geneva: World Health Organization; 2005.
5 Lloyd-Sherlock P. Population ageing in developed and devel-
oping regions: implications for health policy. Soc Sci Med.
2000;51:887–95.
6 Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Ko-
plan JP. The continuing epidemics of obesity and diabetes in
the United States. JAMA. 2001;286:1195–200.
7 Arterburn DE, Crane PK, Sullivan SD. The coming epidemic
of obesity in elderly Americans. J Am Geriatr Soc. 2004;52:
1907–12.
8 Sturm R, Ringel JS, Andreyeva T. Increasing obesity rates and
disability trends. Health Aff (Millwood ) 2004;23:199–205.
9 Field AE, Coakley EH, Must A, Spadano JL, Laird N, Dietz
WH, et al. Impact of overweight on the risk of developing
common chronic diseases during a 10-year period. Arch Intern
Med. 2001;161:1581–6.
10 Visscher TL, Seidell JC. The public health impact of obesity.
Ann Rev Public Health. 2001;22:355–75.
11 Thompson D, Edelsberg J, Colditz GA, Bird AP, Oster G.
Lifetime health and economic consequences of obesity. Arch
Intern Med. 1999;159:2177–83.
12 Elia M. Obesity in the elderly. Obes Res. 2001;9:244S–248S
13 Haslam DW, James WP. Obesity. Lancet. 2005;366:1197–209.
14 Must A, Spadano J, Coakley EH, Colditz G, Dietz WH. The
disease burden associated with overweight and obesity. JAMA.
1999;282:1523–9.
15 Patterson RE, Frank LL, Kristal AR, White E. A comprehen-
sive examination of health conditions associated with obesity in
older adults. Am J Prev Med. 2004;27:385–90.
16 Tunstall-Pepoe H, editor. MONICA monograph and multi-
media sourcebook. Geneva: World Health Organization; 2003.
17 Friedmann JM, Elasy T, Jensen GL. The relationship between
body mass index and self-reported functional limitation among
older adults: a gender difference. J Am Geriatr Soc. 2001;49:
398–403.
18 Launer LJ, Harris T, Rumpel C, Madans J. Body mass index,
weight change, and risk of mobility disability in middle-aged
and older women. The epidemiologic follow-up study of
NHANES I. JAMA. 1994;271:1093–8.
19 Wannamethee SG, Shaper AG, Whincup PH, Walker M.
Overweight and obesity and the burden of disease and disabil-
ity in elderly men. Int J Obes Relat Metab Disord. 2004;28:
1374–82.
20 Börsch-Supan A, Hank K, Jürges H. A new comprehensive and
international view on ageing: introducing the “Survey of
Health, Ageing and Retirement in Europe”. Eur J Ageing.
2005;2:245–53.
21 The survey of health, ageing and retirement in Europe:
Methodology. Mannheim: Mannheim Research Institute for
the Economics of Aging (MEA); 2005.
22 Prince MJ, Reischies F, Beekman AT, Fuhrer R, Jonker C,
Kivela SL, et al. Development of the EURO-D scale – a Euro-
pean Union initiative to compare symptoms of depression in
14 European centres. Br J Psychiatry. 1999;174:330–8.
23 Katz S. Assessing self-maintenance: activities of daily living,
mobility, and instrumental activities of daily living. J Am Geri-
atr Soc. 1983;31:721–7.
24 Larrieu S, Peres K, Letenneur L, Berr C, Dartigues JF, Ritchie
K, et al. Relationship between body mass index and different
domains of disability in older persons: the 3C study. Int J Obes
Relat Metab Disord. 2004;28:1555–60.
25 Lean ME, Han TS, Seidell JC. Impairment of health and qual-
ity of life using new US federal guidelines for the identification
of obesity. Arch Intern Med. 1999;159:837–43.
26 Sulander T, Martelin T, Rahkonen O, Nissinen A, Uutela A.
Associations of functional ability with health-related behavior
and body mass index among the elderly. Arch Gerontol Geri-
atr. 2005;40:185–99.
27 Wolk A, Rossner S. Obesity and self-perceived health in Swe-
den. Int J Obes Relat Metab Disord. 1996;20:369–72.
28 Ferraro KF, Su YP, Gretebeck RJ, Black DR, Badylak SF. Body
mass index and disability in adulthood: a 20-year panel study.
Am J Public Health. 2002;92:834–40.
29 Galanos AN, Pieper CF, Cornoni-Huntley JC, Bales CW, Fil-
lenbaum GG. Nutrition and function: is there a relationship
between body mass index and the functional capabilities of
community-dwelling elderly? J Am Geriatr Soc. 1994;42:368–
73.
30 Peeters A, Bonneux L, Nusselder WJ, De Laet C, Barendregt
JJ. Adult obesity and the burden of disability throughout life.
Obes Res. 2004;12:1145–51.
31 Connor Gorber S, Tremblay M, Moher D, Gorber B. A com-
parison of direct vs self-report measures for assessing height,
weight and body mass index: a systematic review. Obes Rev.
2007;8:307–26.
32 Chiolero A, Peytremann-Bridevaux I, Paccaud F. Associations
between obesity and health conditions may be overestimated if
self-reported body mass index is used. Obes Rev. 2007;8:373–4.
33 Lakdawalla DN, Goldman DP, Shang B. The Health And Cost
Consequences Of Obesity Among The Future Elderly. Health
Aff (Millwood) 2005.
34 Wolf AM, Colditz GA. Current estimates of the economic cost
of obesity in the United States. Obes Res. 1998;6:97–106.
261-266 Pey12067.qxp  18.4.2008  8:40 Uhr  Seite 266
Official journal of the Swiss Society of Infectious Diseases,
the Swiss Society of Internal Medicine and the Swiss Respiratory Society
Supported by the FMH (Swiss Medical Association) and by Schwabe AG,
the long-established scientific publishing house founded in 1488Editores Medicorum Helveticorum
E s t a b l i s h e d i n 1 8 7 1
F o rme r l y : S c hwe i ze r i s c h e Med i z i n i s c h e Wo c h e n s c h r i f t
Sw i s s M e d i c a l W e e k l y
T h e E u r o p e a n J o u r n a l o f M e d i c a l S c i e n c e s
What Swiss Medical Weekly has to offer:
• SMW’s impact factor has been steadily
rising. The 2006 impact factor is 1.346.
• Open access to the publication via
the Internet, therefore wide audience
and impact
• Rapid listing in Medline
• LinkOut-button from PubMed
with link to the full text website
http://www.smw.ch (direct link from
each SMW record in PubMed)
• No-nonsense submission – you submit
a single copy of your manuscript by
e-mail attachment
• Peer review based on a broad spectrum
of international academic referees
• Assistance of professional statisticians
for every article with statistical analyses
• Fast peer review, by e-mail exchange
with the referees
• Prompt decisions based on weekly con-
ferences of the Editorial Board
• Prompt notification on the status of
your manuscript by e-mail
• Professional English copy editing
Editorial Board
Prof. Jean-Michel Dayer, Geneva
Prof Paul Erne, Lucerne
Prof. Peter Gehr, Berne
Prof. André P. Perruchoud, Basel
Prof. Andreas Schaffner, Zurich
(editor in chief)
Prof. Werner Straub, Berne (senior editor)
Prof. Ludwig von Segesser, Lausanne
International Advisory Committee
Prof. K. E. Juhani Airaksinen, Turku, Fin-
land
Prof. Anthony Bayes de Luna, Barcelona,
Spain
Prof. Hubert E. Blum, Freiburg, Germany
Prof. Walter E. Haefeli, Heidelberg, Ger-
many
Prof. Nino Kuenzli, Los Angeles, USA
Prof. René Lutter, Amsterdam,
The Netherlands
Prof. Claude Martin, Marseille, France
Prof. Josef Patsch, Innsbruck, Austria
Prof. Luigi Tavazzi, Pavia, Italy
We evaluate manuscripts of broad clinical
interest from all specialities, including
experimental medicine and clinical in-
vestigation.
We look forward to receiving your paper!
Guidelines for authors:
http://www.smw.ch/set_authors.html
All manuscripts should be sent in electronic
form, to:
EMH Swiss Medical Publishers Ltd.
SMW Editorial Secretariat
Farnsburgerstrasse 8
CH-4132 Muttenz
Manuscripts: submission@smw.ch
Letters to the editor: letters@smw.ch
Editorial Board: red@smw.ch
Internet: http://www.smw.ch
The many reasons why you should choose SMW to publish your research
Call for paper NEU.qxp:1. US SMW 38 28.2.2008 8:10 Uhr Seite 1
